Zacks: Senseonics Holdings Inc (SENS) Given $4.75 Consensus Target Price by Brokerages
Senseonics Holdings Inc (NASDAQ:SENS) has been assigned a consensus broker rating score of 1.50 (Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. Senseonics Holdings’ rating score has declined by 12.8% in the last three months as a result of various analysts’ ratings changes.
Analysts have set a 12 month consensus price target of $4.75 for the company and are forecasting that the company will post ($0.14) EPS for the current quarter, according to Zacks. Zacks has also given Senseonics Holdings an industry rank of 62 out of 265 based on the ratings given to its competitors.
Several research firms recently issued reports on SENS. Canaccord Genuity reiterated a “buy” rating on shares of Senseonics Holdings in a report on Thursday, September 28th. Zacks Investment Research upgraded Senseonics Holdings from a “sell” rating to a “hold” rating in a report on Tuesday, August 15th.
In related news, COO Mukul Jain sold 13,115 shares of Senseonics Holdings stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $3.25, for a total value of $42,623.75. Following the sale, the chief operating officer now directly owns 13,115 shares in the company, valued at approximately $42,623.75. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
A number of hedge funds have recently bought and sold shares of SENS. Raymond James Financial Services Advisors Inc. acquired a new stake in Senseonics Holdings in the 1st quarter worth about $147,000. Renaissance Technologies LLC acquired a new stake in Senseonics Holdings in the 1st quarter worth about $111,000. ING Groep NV boosted its holdings in Senseonics Holdings by 87.7% in the 2nd quarter. ING Groep NV now owns 225,833 shares of the company’s stock worth $406,000 after buying an additional 105,494 shares during the last quarter. NEA Management Company LLC boosted its holdings in Senseonics Holdings by 27.1% in the 2nd quarter. NEA Management Company LLC now owns 33,425,275 shares of the company’s stock worth $60,165,000 after buying an additional 7,119,989 shares during the last quarter. Finally, LMR Partners LLP acquired a new stake in Senseonics Holdings in the 2nd quarter worth about $177,000.
Senseonics Holdings (NASDAQ:SENS) opened at 2.56 on Friday. The stock has a 50 day moving average price of $3.06 and a 200-day moving average price of $3.06. Senseonics Holdings has a 1-year low of $1.26 and a 1-year high of $3.67. The company’s market cap is $315.39 million.
Senseonics Holdings (NASDAQ:SENS) last posted its earnings results on Wednesday, August 9th. The company reported ($0.12) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.13) by $0.01. The business had revenue of $0.81 million for the quarter, compared to analyst estimates of $0.81 million. On average, equities research analysts forecast that Senseonics Holdings will post ($0.54) EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Zacks: Senseonics Holdings Inc (SENS) Given $4.75 Consensus Target Price by Brokerages” was first posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/10/20/zacks-senseonics-holdings-inc-sens-given-4-75-consensus-target-price-by-brokerages.html.
Senseonics Holdings Company Profile
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.